Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,546 | 10,827 | -3,529 | -11,759 | -8,714 |
| Depreciation Amortization | 273 | 202 | 80 | 341 | 256 |
| Accounts receivable | -429 | -528 | -7 | 341 | 263 |
| Accounts payable and accrued liabilities | -1,226 | -1,121 | 1,064 | -683 | -1,417 |
| Other Working Capital | -1,926 | -1,988 | 111 | 238 | -1,549 |
| Other Operating Activity | -12,420 | -12,867 | -229 | 2,619 | 2,820 |
| Operating Cash Flow | $-6,182 | $-5,475 | $-2,508 | $-8,903 | $-8,341 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | N/A | N/A | -8 | -6 |
| Other Investing Activity | 5,387 | 5,160 | 0 | 0 | 0 |
| Investing Cash Flow | $5,386 | $5,160 | $N/A | $-8 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 277 | 262 | 268 | 6,426 | 6,486 |
| Common Stock Repurchased | N/A | N/A | N/A | -44 | N/A |
| Other Financing Activity | -153 | -144 | -79 | -518 | -461 |
| Financing Cash Flow | $123 | $119 | $188 | $5,864 | $6,025 |
| Exchange Rate Effect | 76 | 110 | 112 | -398 | -171 |
| Beginning Cash Position | 4,467 | 4,274 | 4,419 | 7,750 | 7,874 |
| End Cash Position | 3,870 | 4,188 | 1,861 | 4,306 | 5,381 |
| Net Cash Flow | $-597 | $-86 | $-2,558 | $-3,444 | $-2,493 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,182 | -5,475 | -2,508 | -8,903 | -8,341 |
| Capital Expenditure | -2 | N/A | N/A | -8 | -6 |
| Free Cash Flow | -6,183 | -5,475 | -2,508 | -8,910 | -8,347 |